Overweight and obesity before, during and after pregnancy

Geburtshilfe und Frauenheilkunde

Volumn 74, Issue 7, 2014, Pages 639-645

  Stupin, J H ^a,b   Arabin, B ^a,b,c  

^a Clara Angela Foundation   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

adipose tissue; obesity; perinatal programming; pregnancy; prevention

Indexed keywords

FAT; INTERLEUKIN DERIVATIVE; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; EPIGENETICS; EVALUATION STUDY; EVIDENCE BASED PRACTICE; HUMAN; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; MATERNAL HYPERTENSION; MATERNAL OBESITY; MOLECULAR BIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; REVIEW;

EID: 84905389366     PISSN: 00165751     EISSN: 14388804     Source Type: Journal    
DOI: 10.1055/s-0034-1368486     Document Type: Review

References (100)

1. Max Rubner-Institut Nationale Verzehrsstudie II. Ergebnisbericht, Teil 1. 2008. Online: http://www.mri.bund.de last access: 20.01.2014
2. Abbasi F., Brown B. W. jr., Lamendola C. et al. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol: 2002; 40 937 943
3. McLaughlin T., Allison G., Abbasi F. et al. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism: 2004; 53 495 499
4. Catalano P. M., Tyzbir E. D., Roman N. M. et al. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol: 1991; 165 6 Pt 1 1667 1672
5. Catalano P. M., Huston L., Amini S. B. et al. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol: 1999; 180 903 916
6. Athukorala C., Rumbold A. R., Willson K. J. et al. The risk of adverse pregnancy outcomes in women who are overweight or obese. BMC Pregnancy Childbirth: 2010; 10 56
7. Ovesen P., Rassmussen S., Kesmodel U. Effect of prepregnancy overweight and obesity on pregnancy outcome. Obstet Gynecol: 2011; 118 2 Pt 1 305 312
8. Weiss J. L., Malone F. D., Emig D. et al. FASTER Research Consortium Obesity, obstetric complications and cesarean delivery rate - a population-based screening study. Am J Obstet Gynecol: 2004; 190 1091 1097
9. Torloni M. R., Betran A. P., Horta B. L. et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev: 2009; 10 194 203
10. Challis J. R., Lockwood C. J., Myatt L. et al. Inflammation and pregnancy. Reprod Sci: 2009; 16 206 215
11. Wang Z., Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm: 2010; 2010 535918
12. Mangge H., Almer G., Truschnig-Wilders M. et al. Inflammation, adiponectin, obesity and cardiovascular risk. Curr Med Chem: 2010; 17 4511 4520
13. Ramsay J. E., Ferrell W. R., Crawford L. et al. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab: 2002; 87 4231 4237
14. Roberts J. M., Bodnar L. M., Patrick T. E. et al. The role of obesity in preeclampsia. Pregnancy Hypertens: 2011; 1 6 16
15. Zhang Y., Proenca R., Maffei M. et al. Positional cloning of the mouse obese gene and its human homologue. Nature: 1994; 372 425 432
16. Ronti T., Lupattelli G., Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf): 2006; 64 355 365
17. Fischer-Posovszky P., Wabitsch M., Hochberg Z. Endocrinology of adipose tissue - an update. Horm Metab Res: 2007; 39 314 321
18. Gelsinger C., Tschoner A., Kaser S. et al. [Adipokine update - new molecules, new functions]. Wien Med Wochenschr: 2010; 160 377 390
19. Denison F. C., Roberts K. A., Barr S. M. et al. Obesity, pregnancy, inflammation, and vascular function. Reproduction: 2010; 140 373 385
20. Catalano P. M. Trying to understand gestational diabetes. Diabet Med: 2014; 31 273 281
21. Poissonnet C. M., Burdi A. R., Bookstein F. L. Growth and development of human adipose tissue during early gestation. Early Hum Dev: 1983; 8 1 11
22. Martin R. J., Hausman G. J., Hausman D. B. Regulation of adipose cell development in utero. Proc Soc Exp Biol Med: 1998; 219 200 210
23. Poissonnet C. M., Burdi A. R., Garn S. M. The chronology of adipose tissue appearance and distribution in the human fetus. Early Hum Dev: 1984; 10 1 11
24. Knittle J. L., Timmers K., Ginsberg-Fellner F. et al. The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size. J Clin Invest: 1979; 63 239 246
25. Spalding K. L., Arner E., Westermark P. O. et al. Dynamics of fat cell turnover in humans. Nature: 2008; 453 783 787
26. Cinti S. Transdifferentiation properties of adipocytes in the adipose organ. Am J Physiol Endocrinol Metab: 2009; 297 E977 E986
27. Després J. P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature: 2006; 444 881 887
28. Hotamisligil G. S., Shargill N. S., Spiegelman B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science: 1993; 259 87 91
29. Lago F., Dieguez C., Gómez-Reino J. et al. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev: 2007; 18 313 325
30. Maury E., Brichard S. M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol: 2010; 314 1 16
31. Hu E., Liang P., Spiegelman B. M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem: 1996; 271 10697 10703
32. Milan G., Granzotto M., Scarda A. et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res: 2002; 10 1095 1103
33. Huber J., Kiefer F. W., Zeyda M. et al. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab: 2008; 93 3215 3221
34. Fain J. N., Madan A. K., Hiler M. L. et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology: 2004; 145 2273 2282
35. Demerath E. W., Reed D., Rogers N. et al. Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Am J Clin Nutr: 2008; 88 1263 1271
36. Tordjman J., Poitou C., Hugol D. et al. Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. J Hepatol: 2009; 51 354 362
37. Apovian C. M., Bigornia S., Mott M. et al. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol: 2008; 28 1654 1659
38. Poulain-Godefroy O., Lecoeur C., Pattou F. et al. Inflammation is associated with a decrease of lipogenic factors in omental fat in women. Am J Physiol Regul Integr Comp Physiol: 2008; 295 R1 R7
39. Staiger H., Häring H. U. Adipocytokines: fat-derived humoral mediators of metabolic homeostasis. Exp Clin Endocrinol Diabetes: 2005; 113 67 79
40. Radaelli T., Varastehpour A., Catalano P. et al. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes: 2003; 52 2951 2958
41. Hauguel-de Mouzon S., Guerre-Millo M. The placenta cytokine network and inflammatory signals. Placenta: 2006; 27 794 798
42. Challier J. C., Basu S., Bintein T. et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta: 2008; 29 274 281
43. Basu S., Leahy P., Challier J. C. et al. Molecular phenotype of monocytes at the maternal-fetal interface. Am J Obstet Gynecol: 2011; 205 265.e1 265.e8
44. Xu H., Barnes G. T., Yang Q. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest: 2003; 112 1821 1830
45. Hotamisligil G. S. Inflammation and metabolic disorders. Nature: 2006; 444 860 867
46. Farley D., Tejero M. E., Comuzzie A. G. et al. Feto-placental adaptations to maternal obesity in the baboon. Placenta: 2009; 30 752 760
47. Lumeng C. N., Bodzin J. L., Saltiel A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest: 2007; 117 175 184
48. Martin A. M., Berger H., Nisenbaum R. et al. Abdominal visceral adiposity in the first trimester predicts glucose intolerance in later pregnancy. Diabetes Care: 2009; 32 1308 1310
49. Kirwan J. P., Hauguel-De Mouzon S., Lepercq J. et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes: 2002; 51 2207 2213
50. Colomiere M., Permezel M., Riley C. et al. Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. Eur J Endocrinol: 2009; 160 567 578
51. Metzger B. E., Lowe L. P., Dyer A. R. et al. HAPO Study Cooperative Research Group Hyperglycemia and adverse pregnancy outcomes. N Engl J Med: 2008; 358 1991 2002
52. Boomsma C. M., Eijkemans M. J., Hughes E. G. et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update: 2006; 12 673 683
53. Bodnar L. M., Ness R. B., Harger G. F. et al. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol: 2005; 162 1198 1206
54. Plagemann A. 'Fetal programming and 'functional teratogenesis': on epigenetic mechanisms and prevention of perinatally acquired lasting health risks. J Perinat Med: 2004; 32 297 305
55. Catalano P. M., Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol: 2011; 204 479 487
56. Plagemann A., Harder T., Schellong K. et al. Early postnatal life as a critical time window for determination of long-term metabolic health. Best Pract Res Clin Endocrinol Metab: 2012; 26 641 653
57. Pinney S. E., Simmons R. A. Metabolic programming, epigenetics, and gestational diabetes mellitus. Curr Diab Rep: 2012; 12 67 74
58. Plagemann A. Toward a unifying Concept on perinatal Programming: vegetative Imprinting by Environment-dependent Biocybernetogenesis. In: Plagemann A. ed. Perinatal Programming. The State of the Art. Berlin, Boston de Gruyter: 2012; 243 282
59. Ruchat S. M., Hivert M. F., Bouchard L. Epigenetic programming of obesity and diabetes by in utero exposure to gestational diabetes mellitus. Nutr Rev: 2013; 71 01 S88 S94
60. Plagemann A. Perinatal programming and functional teratogenesis: impact on body weight regulation and obesity. Physiol Behav: 2005; 86 661 668
61. Plagemann A., Harder T., Dudenhausen J. W. The diabetic pregnancy, macrosomia, and perinatal nutritional programming. Nestle Nutr Workshop Ser Pediatr Program: 2008; 61 91 102
62. Harder T., Rodekamp E., Schellong K. et al. Adipositas und perinatale Programmierung. In: Plagemann A., Dudenhausen J. W. Hrsg. Adipositas als Risiko in der Perinatalmedizin. München Springer: 2010; 72 81
63. Plagemann A. Maternal diabetes and perinatal programming. Early Hum Dev: 2011; 87 743 747
64. Plagemann A., Harder T. Fuel-mediated teratogenesis and breastfeeding. Diabetes Care: 2011; 34 779 781
65. Stupin J. H., Harder T., Plagemann A. [Fetal programming during diabetic pregnancy.]. Adipositas: 2011; 5 134 140
66. Dörner G., Mohnike A. Further evidence for a predominantly maternal transmission of maturity-onset type diabetes. Endokrinologie: 1976; 68 121 124
67. Dörner G. Perinatal Hormone Levels and Brain Organization. In: Stumpf W., Grant L. D. eds. Anatomical Neuroendocrinology. Basel Karger: 1975; 245 252
68. Hales C. N., Barker D. J. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia: 1992; 35 595 601
69. Bergmann R. L., Richter R., Bergmann K. E. et al. Secular trends in neonatal macrosomia in Berlin: influences of potential determinants. Paediatr Perinat Epidemiol: 2003; 17 244 249
70. Harder T., Plagemann A. The intrauterine environmental adipogenesis. J Pediatr: 2004; 144 551 552
71. Hesse V., Voigt M., Sälzler A. et al. Alterations in height, weight, and body mass index of newborns, children, and young adults in eastern Germany after German reunification. J Pediatr: 2003; 142 259 262
72. Sewell M. F., Huston-Presley L., Super D. M. et al. Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol: 2006; 195 1100 1103
73. Cedergren M. I. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol: 2004; 103 219 224
74. Mission J. F., Marshall N. E., Caughey A. B. Obesity in pregnancy: a big problem and getting bigger. Obstet Gynecol Surv: 2013; 68 389 399
75. Galtier-Dereure F., Boegner C., Bringer J. Obesity and pregnancy: complications and cost. Am J Clin Nutr: 2000; 71 5 Suppl. 1242S 1248S
76. Helms E., Coulson C. C., Galvin S. L. Trends in weight gain during pregnancy: a population study across 16 years in North Carolina. J Obstet Gynecol: 2006; 194 e32 e34
77. Harder T., Schellong K., Stupin J. et al. Where is the evidence that low birthweight leads to obesity? Lancet: 2007; 369 1859
78. Schellong K., Schulz S., Harder T. et al. Birth weight and long-term overweight risk: systematic review and a meta-analysis including 643,902 persons from 66 studies and 26 countries globally. PLoS One: 2012; 7 e47776
79. Harder T., Rodekamp E., Schellong K. et al. Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol: 2007; 165 849 857
80. Dabelea D., Hanson R. L., Lindsay R. S. et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes: 2000; 49 2208 2211
81. Pettitt D. J., Baird H. R., Aleck K. A. et al. Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. N Engl J Med: 1983; 308 242 245
82. Plagemann A., Harder T., Kohlhoff R. et al. Overweight and obesity in infants of mothers with long-term insulin-dependent diabetes or gestational diabetes. Int J Obes Relat Metab Disord: 1997; 21 451 456
83. Plagemann A., Harder T., Kohlhoff R. et al. Glucose tolerance and insulin secretion in children of mothers with pregestational IDDM or gestational diabetes. Diabetologia: 1997; 40 1094 1100
84. Silverman B. L., Rizzo T., Green O. C. et al. Long-term prospective evaluation of offspring of diabetic mothers. Diabetes: 1991; 40 02 121 125
85. Prince A., Ma J., Bader D. et al. Maternal diet persistently alters the developing juvenile microbiome in a primate model of obesity (abstract). Am J Obstet Gynecol: 2014; 210 01 S30
86. Seet E., Yee J., Ross M. et al. Programmed adipogenesis and obesity in offspring of obese dams (abstract). Am J Obstet Gynecol: 2014; 210 01 S33
87. Bytautiene E., Kechichian T., Syes T. et al. Accelerated aging in the offspring of mothers with pre-pregnancy obesity in a mouse model of developmental programming of metabolic syndrome (abstract). Am J Obstet Gynecol: 2014; 210 01 S30 S31
88. Bytautiene E., Banerjee D., Kechichian T. et al. Adipose tissue dysfunction in a model of developmental programming of metabolic syndrome. Am J Obstet Gynecol: 2014; 210 01 S97
89. Dörner G., Plagemann A. Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk in later life. Horm Metab Res: 1994; 26 213 221
90. Plagemann A., Harder T., Brunn M. et al. Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome. J Physiol: 2009; 587 Pt 20 4963 4976
91. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev: 2002; 16 6 21
92. Heijmans B. T., Tobi E. W., Stein A. D. et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A: 2008; 105 17046 17049
93. Bouchard L., Thibault S., Guay S. P. et al. Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy. Diabetes Care: 2010; 33 2436 2441
94. Tobi E. W., Heijmans B. T., Kremer D. et al. DNA methylation of IGF2, GNASAS, INSIGF and LEP and being born small for gestational age. Epigenetics: 2011; 6 171 176
95. Filiberto A. C., Maccani M. A., Koestler D. et al. Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta. Epigenetics: 2011; 6 566 572
96. Bouchard L., Hivert M. F., Guay S. P. et al. Placental adiponectin gene DNA methylation levels are associated with mothers' blood glucose concentration. Diabetes: 2012; 61 1272 1280
97. Nomura Y., Lambertini L., Rialdi A. et al. Global methylation in the placenta and umbilical cord blood from pregnancies with maternal gestational diabetes, preeclampsia, and obesity. Reprod Sci: 2014; 21 131 137
98. Ghaffari N., Parry S., Durnwald C. The role of miRNA in fetal programming of obesity. Am J Obstet Gynecol: 2014; 210 01 S70
99. Nathanielsz P. W., Ford S. P., Long N. M. et al. Interventions to prevent adverse fetal programming due to maternal obesity during pregnancy. Nutr Rev: 2013; 71 01 S78 S87
100. Institute of Medicine (IOM) Weight Gain during Pregnancy: re-examining the Guidelines. Committee to Reexamine IOM Pregnancy Weight Guidelines. Washington National Research Council: 2009